Kalafatis: Greece produces 50% of Europe’s oncology drugs, 30% of cardio-metabolic drugs and 25% of penicillin drugs

“In a world where biomedical research, new digital technologies and Artificial Intelligence are transforming healthcare systems, strengthening cooperation between the state, industry, the academic and research community, and the innovation… Kalafatis: Greece produces 50% of Europe’s oncology drugs, 30% of cardio-metabolic drugs and 25% of penicillin drugs - Η ΝΑΥΤΕΜΠΟΡΙΚΗ

By Μιχάλης Ματσίγκος